American heart journal

01 19 October 2026

DOI 10.1016/j.ahj.2026.107628

Design of Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT-Echo-AI)

Open DOI

Sahir Eusuff, Jay Kim, Zara Fatima et al.

02 18 October 2026

DOI 10.1016/j.ahj.2026.107631

A randomized controlled trial of a novel AI-based prognostic decision support tool integrated into the electronic health record for ischemic heart disease: Rationale and design of the PM Heart trial

Open DOI

Anna Kirstine Ringgaard, Søren Albertsen Rand, Chaoqun Zheng et al.

03 13 October 2026

DOI 10.1016/j.ahj.2026.107629

Mechanism of Mortality in Individuals with Elevated Risk Pulmonary Emboli: A Multicenter Analysis of a Contemporary Cohort

Open DOI

Zach Rozenbaum, Eric Gnall, Ali Gholam et al.

04 13 October 2026

DOI 10.1016/j.ahj.2026.107625

A 0/2-Hour Algorithm Using a Novel Point-of-Care High-Sensitivity Cardiac Troponin I Assay for Suspected Myocardial Infarction

Open DOI

Luca Koechlin, Pedro Lopez-Ayala, Jasper Boeddinghaus et al.

05 11 October 2026

DOI 10.1016/j.ahj.2026.107630

Pulsed field ablation with Renal denervation for persistent Atrial fibrIllation: Rationale and design of the PRAISE-AF randomized trial

Open DOI

Jiongchao Guo, Mu Qin, Weifeng Jiang et al.

06 10 October 2026

DOI 10.1016/j.ahj.2026.107613

Corrigendum to The European Bifurcation Club randomised trial of stepwise provisional stenting versus Drug Coated Balloon therapy for non-left main true coronary bifurcations: The EBC DCB Trial American Heart Journal: Volume 300, October 2026, 107463

Open DOI

Christopher J Broyd, Sandeep Arunothayaraj, Bruno Scheller et al.

07 9 October 2026

DOI 10.1016/j.ahj.2026.107627

Design and Rationale of the CLASP II TR Randomized Trial for Severe Tricuspid Regurgitation

Open DOI

Gorav Ailawadi, Charles J. Davidson, Allen S. Anderson et al.

08 6 October 2026

DOI 10.1016/j.ahj.2026.107621

Sex-based differences in mortality and prognostic factors for infective endocarditis: insights from a retrospective cohort of 519 patients

Open DOI

Marie Vincent, Claire Samant, Robinson Gravier-Dumonceau et al.

09 6 October 2026

DOI 10.1016/j.ahj.2026.107622

Design and rationale of the Urine Sodium-directed Diuretic Adjustment Strategy in Heart Failure (US-DASH) trial

Open DOI

Andrew Lurie, Padideh Daneii, Chia-Hung Sze et al.

10 6 October 2026

DOI 10.1016/j.ahj.2026.107626

Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3)

Open DOI

Matthew A. Cavender, Ania M. Jastreboff, Alice Y.Y. Cheng et al.